Strategic Combination of DNA-Damaging Agent and PARP Inhibitor Results in Enhanced Cytotoxicity
about
Effect of adriamycin on BRCA1 and PARP-1 expression in MCF-7 breast cancer cells.Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition.Cytotoxic effects of fascaplysin against small cell lung cancer cell lines.Cisplatin resistance in germ cell tumours: models and mechanisms.Design, Synthesis, and Biological Evaluation of Novel PARP-1 Inhibitors Based on a 1H-Thieno[3,4-d] Imidazole-4-Carboxamide Scaffold.Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics.Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function.PARP inhibitors protect against sex- and AAG-dependent alkylation-induced neural degeneration.Population pharmacokinetics of ABT-767 in BRCA1 or BRCA2 mutation carriers with advanced solid tumors or in subjects with high grade serous ovarian, primary peritoneal or fallopian tube cancer.The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale).Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair.
P2860
Q34371454-2C39E551-B031-4B56-835E-DFFE45E5691BQ36544857-8C4EA767-37F3-4F19-9AEB-E6F83205D45DQ37666991-70AC4902-8A14-4130-864B-4630C80F45EAQ38302534-CB26746F-4F80-47F3-924F-8E102B677EE9Q38764341-185FF098-D090-4AD2-8927-F4FF6782190FQ41472115-C4978DBE-1377-4F21-8EBC-A36F80EB4ED1Q41539026-86D20D29-C2D2-4200-B3A3-B773756C5A78Q42366639-E97BD1AD-59A0-4D5B-81BA-C2A7FF4B22F2Q51117836-F1373AA2-180D-45C5-A038-0C60A62CC989Q54974198-F95C7A10-9CFC-40FB-9F7F-47AC882F9262Q55315687-DE829CA8-3B8C-4460-880F-A9D482F04B24
P2860
Strategic Combination of DNA-Damaging Agent and PARP Inhibitor Results in Enhanced Cytotoxicity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Strategic Combination of DNA-D ...... sults in Enhanced Cytotoxicity
@en
Strategic Combination of DNA-D ...... ults in Enhanced Cytotoxicity.
@nl
type
label
Strategic Combination of DNA-D ...... sults in Enhanced Cytotoxicity
@en
Strategic Combination of DNA-D ...... ults in Enhanced Cytotoxicity.
@nl
prefLabel
Strategic Combination of DNA-D ...... sults in Enhanced Cytotoxicity
@en
Strategic Combination of DNA-D ...... ults in Enhanced Cytotoxicity.
@nl
P2860
P356
P1476
Strategic Combination of DNA-D ...... sults in Enhanced Cytotoxicity
@en
P2093
Julie K Horton
P2860
P356
10.3389/FONC.2013.00257
P577
2013-09-30T00:00:00Z